Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Methadone as Co-Opioid Analgesic in Cancer Patients
NCT00558870Phase 2Terminated
- Sponsor
- University of Texas MD Anderson Cancer Center
- Start
- Nov 2007
- Primary completion
- Jan 2015
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of methadone in cancer pain (2 arms), sponsored by University of Texas MD Anderson Cancer Center. Primary endpoints: Number of Participants With Objective Response at Day 15 and Dose Escalation Index at Day 15. Started Nov 2007; status: terminated.
02
Drugs
methadone
03
Conditions
cancer pain
Beyond the preview
Go deeper on NCT00558870.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00558870.